These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12173813)

  • 1. Novel anti-factor D monoclonal antibody inhibits complement and leukocyte activation in a baboon model of cardiopulmonary bypass.
    Undar A; Eichstaedt HC; Clubb FJ; Fung M; Lu M; Bigley JE; Vaughn WK; Fraser CD
    Ann Thorac Surg; 2002 Aug; 74(2):355-62; discussion 362. PubMed ID: 12173813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass.
    Fitch JC; Rollins S; Matis L; Alford B; Aranki S; Collard CD; Dewar M; Elefteriades J; Hines R; Kopf G; Kraker P; Li L; O'Hara R; Rinder C; Rinder H; Shaw R; Smith B; Stahl G; Shernan SK
    Circulation; 1999 Dec 21-28; 100(25):2499-506. PubMed ID: 10604887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anesthetic induction with ketamine inhibits platelet activation before, during, and after cardiopulmonary bypass in baboons.
    Undar A; Eichstaedt HC; Clubb FJ; Lu M; Bigley JE; Deady BA; Porter A; Vaughn WK; Fung M
    Artif Organs; 2004 Oct; 28(10):959-62. PubMed ID: 15385005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits.
    Fung M; Loubser PG; Undar A; Mueller M; Sun C; Sun WN; Vaughn WK; Fraser CD
    J Thorac Cardiovasc Surg; 2001 Jul; 122(1):113-22. PubMed ID: 11436043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of the inflammatory response: adhesion molecules associated with platelet/white cell responses.
    Rinder C; Fitch J
    J Cardiovasc Pharmacol; 1996; 27 Suppl 1():S6-12. PubMed ID: 8938278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-selectin monoclonal antibody may attenuate the whole body inflammatory response induced by cardiopulmonary bypass.
    Hayashi Y; Sawa Y; Nishimura M; Tojo SJ; Ichikawa H; Satoh H; Yamaguchi T; Suhara H; Ohtake S; Matsuda H
    ASAIO J; 2000; 46(3):334-7. PubMed ID: 10826747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement and neutrophil activation during cardiopulmonary bypass: a randomized comparison of hypothermic and normothermic circulation.
    Chello M; Mastroroberto P; Romano R; Ascione R; Pantaleo D; De Amicis V
    Eur J Cardiothorac Surg; 1997 Jan; 11(1):162-8. PubMed ID: 9030806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light and electron microscopic analyses for ischaemia-reperfusion lung injury in an ovine cardiopulmonary bypass model.
    Kim WG; Lee BH; Seo JW
    Perfusion; 2001 May; 16(3):207-14. PubMed ID: 11419656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation, cytokines, and adhesion molecules in children undergoing cardiac surgery with or without cardiopulmonary bypass.
    Tárnok A; Hambsch J; Emmrich F; Sack U; van Son J; Bellinghausen W; Borte M; Schneider P
    Pediatr Cardiol; 1999; 20(2):113-25. PubMed ID: 9986887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation in coronary artery bypass grafting patients without cardiopulmonary bypass: the role of tissue injury by surgical incision.
    Gu YJ; Mariani MA; Boonstra PW; Grandjean JG; van Oeveren W
    Chest; 1999 Oct; 116(4):892-8. PubMed ID: 10531149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of dextran sulfate to blood cardioplegia attenuates reperfusion injury in a porcine model of cardiopulmonary bypass.
    Banz Y; Rieben R; Zobrist C; Meier P; Shaw S; Lanz J; Carrel T; Berdat P
    Eur J Cardiothorac Surg; 2008 Sep; 34(3):653-60. PubMed ID: 18572413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pericardial blood processing on postoperative inflammation and the complement pathways.
    Marcheix B; Carrier M; Martel C; Cossette M; Pellerin M; Bouchard D; Perrault LP
    Ann Thorac Surg; 2008 Feb; 85(2):530-5. PubMed ID: 18222258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement and neutrophil activation during cardiopulmonary bypass: a study in the complement-deficient dog.
    Gillinov AM; Redmond JM; Winkelstein JA; Zehr KJ; Herskowitz A; Baumgartner WA; Cameron DE
    Ann Thorac Surg; 1994 Feb; 57(2):345-52. PubMed ID: 7906115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of methylprednisolone and a biocompatible copolymer circuit on blood activation during cardiopulmonary bypass.
    Rubens FD; Nathan H; Labow R; Williams KS; Wozny D; Karsh J; Ruel M; Mesana T
    Ann Thorac Surg; 2005 Feb; 79(2):655-65. PubMed ID: 15680854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of parecoxib on systemic inflammatory response associated with cardiopulmonary bypass during cardiac surgery.
    Wu Q; Purusram G; Wang H; Yuan R; Xie W; Gui P; Dong N; Yao S
    Br J Clin Pharmacol; 2013 Mar; 75(3):769-78. PubMed ID: 22835079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of cardiopulmonary bypass decreases leukocyte count and activation of the complement system].
    Bochenek A; Religa Z; Kokot F; Knapik P; Wnuk R; Komarski K; Wojnar J; Pietrzycki A; Skiba J
    Kardiol Pol; 1992; 36(2):67-72. PubMed ID: 1583828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of two different perfusion systems on inflammatory response in pediatric heart surgery.
    Jensen E; Andréasson S; Bengtsson A; Berggren H; Ekroth R; Lindholm L; Ouchterlony J
    Ann Thorac Surg; 2003 Mar; 75(3):919-25. PubMed ID: 12645717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
    Gu YJ; Boonstra PW; Rijnsburger AA; Haan J; van Oeveren W
    Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-C5a monoclonal antibody reduces cardiopulmonary bypass and cardioplegia-induced coronary endothelial dysfunction.
    Tofukuji M; Stahl GL; Agah A; Metais C; Simons M; Sellke FW
    J Thorac Cardiovasc Surg; 1998 Dec; 116(6):1060-8. PubMed ID: 9832699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypass.
    Gillinov AM; DeValeria PA; Winkelstein JA; Wilson I; Curtis WE; Shaw D; Yeh CG; Rudolph AR; Baumgartner WA; Herskowitz A
    Ann Thorac Surg; 1993 Mar; 55(3):619-24. PubMed ID: 8383955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.